AbsEn.i
Curation
Istex
Racine
Curation
Checkpoint
Istex
Racine
Istex
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Curation (Istex)

Index « AbsEn.i » - entrée « event »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
even < event < events  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 14.
Ident.Authors (with country if any)Title
000014 (2012) Seiji Ohtori [Japon] ; Masayuki Miyagi [Japon] ; Yawara Eguchi [Japon] ; Gen Inoue [Japon] ; Sumihisa Orita [Japon] ; Nobuyasu Ochiai [Japon] ; Shunji Kishida [Japon] ; Kazuki Kuniyoshi [Japon] ; Junichi Nakamura [Japon] ; Yasuchika Aoki [Japon] ; Tetsuhiro Ishikawa [Japon] ; Gen Arai [Japon] ; Hiroto Kamoda [Japon] ; Miyako Suzuki [Japon] ; Masashi Takaso [Japon] ; Takeo Furuya [Japon] ; Gou Kubota [Japon] ; Yoshihiro Sakuma [Japon] ; Yasuhiro Oikawa [Japon] ; Tomoaki Toyone [Japon] ; Kazuhisa Takahashi [Japon]Efficacy of epidural administration of anti-interleukin-6 receptor antibody onto spinal nerve for treatment of sciatica
000016 (2009) Mao Mao An [République populaire de Chine] ; Zui Zou [République populaire de Chine] ; Hui Shen [République populaire de Chine] ; Jun Dong Zhang [République populaire de Chine] ; Yong Bing Cao [République populaire de Chine] ; Yuan Ying Jiang [République populaire de Chine]The addition of tocilizumab to DMARD therapy for rheumatoid arthritis: a meta-analysis of randomized controlled trials
000084 (2016) T. Flaig [Allemagne] ; A. Douros [Allemagne] ; E. Bronder [Allemagne] ; A. Klimpel [Allemagne] ; R. Kreutz [Allemagne] ; E. Garbe [Allemagne]Tocilizumab‐induced pancreatitis: case report and review of data from the FDA Adverse Event Reporting System
000144 (2012) U. Lange [Allemagne] ; U. Müller-Ladner [Allemagne]Potenzielle rheumatologische Medikamentenwechselwirkungen im Alter
000636 (2013) M. Bodro [Espagne, Australie] ; D. L. Paterson [Australie]Listeriosis in patients receiving biologic therapies
000807 (2013) R. Fleischmann [États-Unis] ; S. Fiore ; C. Fan ; D. Thompson [États-Unis]SAT0136 Sarilumab, a Fully Human Mab Against IL-6R Alpha, Subcutaneously-Administered Shows Significant Improvement in Ra Patients as Early as 2 Weeks: A Time to Event Analysis for Acr50 and Eular Good Response
000946 (2012) Eamonn S. Molloy [Irlande (pays)] ; Leonard H. Calabrese [États-Unis]Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: Evolving role of biologic therapies
000956 (2009) Larry W. Moreland [États-Unis]Cytokines as Targets for Anti‐inflammatory Agents
000958 (2009) Ewa M. Paleolog [Royaume-Uni]The vasculature in rheumatoid arthritis: cause or consequence?
000A17 (2013) D. Furst [États-Unis] ; K. L. Winthrop [États-Unis] ; K. A. Alexander ; A. Vashishtha ; S. F. Francom ; K. G. Saag [États-Unis]FRI0223 Long-term targeted safety event rates in ra patients following initiation of rituximab: interim analysis from sunstone registry
000A88 (2012) Niklas Schmedt [Allemagne] ; Frank Andersohn [Allemagne] ; Edeltraut Garbe [Allemagne]Signals of progressive multifocal leukoencephalopathy for immunosuppressants: a disproportionality analysis of spontaneous reports within the US Adverse Event Reporting System (AERS)
000C91 (2016) Yannick Allanore [France]Physiopathologie de la sclérodermie systémique
001263 (2012) Michael Yellin [États-Unis] ; Igor Paliienko [Ukraine] ; Andra Balanescu [Roumanie] ; Semen Ter-Vartanian [Ukraine] ; Vira Tseluyko [Ukraine] ; Li-An Xu [États-Unis] ; Xiaolu Tao [États-Unis] ; Pina M. Cardarelli [États-Unis] ; Heidi Leblanc [États-Unis] ; Geoff Nichol [États-Unis] ; Codrina Ancuta [Roumanie] ; Rodica Chirieac [Roumanie] ; Allison Luo [États-Unis]A phase II, randomized, double‐blind, placebo‐controlled study evaluating the efficacy and safety of MDX‐1100, a fully human anti‐CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis
001295 (2013) D. Gilroy [Royaume-Uni]SP0135 Mononuclear cells and the reoslution of acute inflammation

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "event" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "event" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    event
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021